Global Brain Edema Market Size, Growth, Trends, Industry Analysis and Forecast 2016 – By Acute Market Reports

General Comments Off on Global Brain Edema Market Size, Growth, Trends, Industry Analysis and Forecast 2016 – By Acute Market Reports

Acute Market Reports, ‘Brain Edema – Pipeline Review, H1 2016’, provides an overview of the Brain Edema pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Brain Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Brain Edema and features dormant and discontinued projects.

Browse Full Report Visit –

Acute Market Reports features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Browse All Reports of This Category –

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


– The report provides a snapshot of the global therapeutic landscape of Brain Edema
– The report reviews pipeline therapeutics for Brain Edema by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Brain Edema therapeutics and enlists all their major and minor projects
– The report assesses Brain Edema therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Brain Edema

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Brain Edema
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Brain Edema pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Get Complete Report @ Brain Edema – Pipeline Review, H1 2016

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Brain Edema Overview 6
Therapeutics Development 7
Pipeline Products for Brain Edema – Overview 7
Pipeline Products for Brain Edema – Comparative Analysis 8
Brain Edema – Therapeutics under Development by Companies 9
Brain Edema – Therapeutics under Investigation by Universities/Institutes 10
Brain Edema – Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Brain Edema – Products under Development by Companies 13
Brain Edema – Products under Investigation by Universities/Institutes 14
Brain Edema – Companies Involved in Therapeutics Development 15
FibroGen, Inc. 15
Pharmazz, Inc. 16
Remedy Pharmaceuticals, Inc. 17
Brain Edema – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessment by Mechanism of Action 21
Assessment by Route of Administration 23
Assessment by Molecule Type 24
Drug Profiles 26
AER-271 – Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Drugs to Modulate Aquaporin Channels for Brain Edema and Cancer – Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
FG-4497 – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
glyburide – Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
PMZ-2123 – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecules to Block Aquaporin-4 for Brain Edema – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Brain Edema – Recent Pipeline Updates 35
Brain Edema – Dormant Projects 37
Brain Edema – Product Development Milestones 38
Featured News & Press Releases 38
Apr 11, 2016: Remedy Pharmaceuticals Announces Two Oral Presentations on Results of CNS-Related Edema Trial At Annual American Academy of Neurology Meeting 38
Apr 06, 2016: Remedy Pharmaceuticals Issues First Quarter 2016 Report 39
Mar 04, 2016: Remedy Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting With FDA on a Novel Drug Treatment for CNS-Related Edema 39
Feb 22, 2016: Remedy Pharmaceuticals Announces Additional Results From Phase 2 CNS-Related Edema Study of CIRARA Presented at International Stroke Conference 39
Feb 08, 2016: Remedy Pharmaceuticals Announces Acceptance of Two Oral Presentations on Phase 2 Results of CIRARA for CNS-Related Edema at ISC 2016 40
Jan 05, 2016: CNS-Related Edema Company Remedy Pharmaceuticals Strengthens Leadership Team in Preparation for Phase 3 Trial 41
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 43
Disclaimer 44

Latest Reports :

Global LED Tube Light Market Research Report 2016

Global LED Reflector Lamp Market Research Report 2016

Global LED Indicator Lamp Market Research Report 2016
About – Acute Market Reports :

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us : 
Chris Paul
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email :
Website :


Back to Top